The 10-second takeaway
For the quarter ended Dec. 31 (Q4), WellPoint met expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew slightly and GAAP earnings per share expanded significantly.
Gross margins increased, operating margins contracted, net margins grew.
WellPoint logged revenue of $15.27 billion. The 16 analysts polled by S&P Capital IQ hoped for revenue of $15.30 billion on the same basis. GAAP reported sales were 1.4% higher than the prior-year quarter's $15.32 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.03. The 20 earnings estimates compiled by S&P Capital IQ forecast $0.94 per share. GAAP EPS of $1.51 for Q4 were 57% higher than the prior-year quarter's $0.96 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 20.4%, 160 basis points better than the prior-year quarter. Operating margin was 4.1%, 10 basis points worse than the prior-year quarter. Net margin was 3.0%, 80 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $17.60 billion. On the bottom line, the average EPS estimate is $2.38.
Next year's average estimate for revenue is $70.82 billion. The average EPS estimate is $7.93.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 952 members out of 1,008 rating the stock outperform, and 56 members rating it underperform. Among 342 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 334 give WellPoint a green thumbs-up, and eight give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on WellPoint is outperform, with an average price target of $69.88.
Is WellPoint the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add WellPoint to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool recommends WellPoint. The Motley Fool owns shares of WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.